Drug · DIN 02238151
MALARONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 20, 2002; first marketed August 7, 1998.
- Drug Identification Number (DIN)
- 02238151
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Proguanil and atovaquone P01BB51
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ATOVAQUONE | 250 MG | |
| PROGUANIL HYDROCHLORIDE | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 24, 2001: NOC 877New Drug Submission (NDS) · Change in manufacturer name
- June 22, 1998: NOC 2682New Drug Submission (NDS)